Abdul Rahim
About Abdul Rahim
Abdul Rahim is a Global Regulatory Affairs CMC (Cell and Gene) professional currently working at Bristol Myers Squibb, with extensive experience in biologics and small molecules.
Current Role and Responsibilities at Bristol Myers Squibb
Abdul Rahim currently holds the position of Global Regulatory Affairs CMC (Cell and Gene) at Bristol Myers Squibb. He began this role in December 2021. His responsibilities include overseeing regulatory aspects of Chemistry, Manufacturing, and Controls (CMC) specifically for cell and gene therapy products. Abdul's role involves ensuring regulatory compliance and facilitating regulatory submissions to support the approval and commercialization of innovative therapies.
Previous Experience at Novartis
From 2019 to 2021, Abdul Rahim worked at Novartis as Global Regulatory Affairs-CMC (Cell and Gene) in the Greater New York City Area. His role involved managing regulatory strategies for cell and gene therapy products. His contributions included preparing regulatory submissions and ensuring adherence to regulatory requirements to advance Novartis's cell and gene therapy portfolio.
Prior Roles at Incyte and Regeneron Pharmaceuticals
Abdul Rahim served as Global CMC Regulatory (Biologics and Small Molecules) at Incyte from 2018 to 2019 in the Greater Philadelphia Area. Before that, he worked at Regeneron Pharmaceuticals, Inc. in various roles, including Regulatory Affairs Specialist, CMC (Biologics) from 2016 to 2018, and Research Associate II, CMC (Protein Biochemistry) from 2013 to 2016 in Tarrytown, NY. These roles involved regulatory oversight for biologics and small molecules, supporting drug discovery, and development processes in CMC regulatory affairs.
Educational Background in Regulatory Affairs and Biotechnology
Abdul Rahim holds a Master of Science (MS) in Regulatory Affairs and Health Policy from Massachusetts College of Pharmacy and Health Sciences. He also earned a Bachelor of Science (B.S.) in Biotechnology from the University of Central Florida - College of Medicine. His academic background provides a strong foundation for his expertise in regulatory affairs and drug development.
Professional Expertise and Experience
Throughout his career, Abdul Rahim has gained extensive experience in analytical development of biologics. He has supported the comparability of monoclonal antibodies (mAbs) and performed process performance qualification (PPQ) analysis for Investigational New Drug (IND) and Biologics License Application (BLA) filings. His deep understanding of drug discovery and development processes, particularly in the context of Chemistry, Manufacturing, and Controls (CMC) for biologics, underscores his expertise in the field.